NASDAQ:MRNA (Moderna)

About MRNA

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
  • Moderna (NASDAQ: MRNA) Latest News

    Investing Articles

    Down 87%, is this once-famous stock set to explode like the Rolls-Royce share price?

    Unlike the roaring Rolls-Royce share price, this growth stock and former household name has totally bombed. But is it due…

    Read more »

    Investing Articles

    1 exciting growth stock to buy for the long run in June

    Shares of Moderna have more than doubled since mid-November. Here's why this writer thinks it's now a stock to buy…

    Read more »

    Investing Articles

    1 intriguing growth stock that could send Scottish Mortgage shares above £10

    Scottish Mortgage shares have been recovering nicely, boosted by a very strong performance in one of the trust's largest holdings.

    Read more »

    Young Asian man drinking coffee at home and looking at his phone
    Investing Articles

    7 shares that Fools have been buying!

    Our Foolish freelancers are putting their money where their mouths are and buying these shares in recent weeks.

    Read more »

    Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
    Investing Articles

    After ChatGPT and Temu, what could be the biggest 2024 stock market winners?

    This writer takes a look at a couple of interesting areas of the stock market that he thinks could be…

    Read more »

    Businesswoman analyses profitability of working company with digital virtual screen
    Investing Articles

    2 growth stocks I’d buy for the artificial intelligence (AI) revolution in 2024

    Ben McPoland takes a look at two intriguing and yet under-the-radar growth stocks that could deliver huge long-term returns.

    Read more »

    Tabletop model of a bear sat on desk in front of monitors showing stock charts
    Investing Articles

    Down 49% and 71%! 2 Nasdaq stocks to buy today

    Ben McPoland considers potential opportunities thrown up by the sell-off in growth shares. Here are two US stocks to buy…

    Read more »

    Investing Articles

    If I’d invested £1,000 in Moderna shares 2 years ago, here’s what I’d have now!

    Dr James Fox explores whether Moderna shares would have been a good investment two years ago, and takes a closer…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    3 stocks that could drive Scottish Mortgage shares higher in 2023

    Scottish Mortgage shares are linked to the value of stocks in the investment trust's portfolio. Our writer identifies three with…

    Read more »

    View over Old Man Of Storr, Isle Of Skye, Scotland
    Growth Shares

    Scottish Mortgage Investment Trust: 3 stocks to help its rebound in 2023

    Scottish Mortgage Investment Trust shares crashed last year, dropping 45%. So, here are three stocks that could help stage its…

    Read more »

    BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
    Investing Articles

    9 shares that Fools have been buying!

    Our Foolish freelancers are putting their money where their mouths are and buying shares in these equities in recent weeks.

    Read more »